Patients Given Access to Experimental Drugs
In August, the Senate passed a bill that gives terminally
ill patients a way to request experimental drugs. On May 29, the House voted 250-169 in favor
of the bill, and it will now be sent to President Trump. The bill, known as the “Right
to Try” bill, gives terminally ill patients the right to seek drug
treatments not fully approved by the FDA. It is controversial, but those in opposition
do see some benefits – such as an increase in the information available on
drugs and greater awareness on options for the terminally ill.